XML 84 R40.htm IDEA: XBRL DOCUMENT v3.22.0.1
Basis of Presentation, Uses of Estimates and Significant Accounting Policies (Details)
$ in Millions
12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Accounts Receivable, after Allowance for Credit Loss, Current $ 14,216 $ 12,870  
Other current receivables 13,866 12,534  
Accounts payable and accrued liabilities 24,643 22,495  
Other Liabilities, Current $ 22,975 20,392  
Number Of Days Notice Required To Cancel Health Insurance Contract 30 days    
Goodwill, Impairment Loss $ 0 0 $ 0
Impairment of Intangible Assets (Excluding Goodwill) 0 0 $ 0
Other Current Liabilities [Member]      
Health savings account deposits $ 11,400 10,200  
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 4 years    
Employee Stock Purchase Plan (ESPP) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date 10.00%    
Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 4 years    
Share-based Compensation Arrangement by Share-based Payment Plan Award, Options, Award Exercisable Period 10 years    
Health Insurance Product Line [Member]      
Short-duration Insurance Contracts, Historical Claims Duration, First 90 Days 0.90    
Products and services [Member]      
Accounts Receivable, after Allowance for Credit Loss, Current $ 5,400 5,300  
Pharmaceutical Manufacturer Rebates Receivable [Member]      
Other current receivables 7,200 6,300  
Medicare Part D Receivables [Member]      
Other current receivables $ 3,400 $ 2,900